Consumer Defensive
Zoono Group Limited(ZOONF)
Live Price
Offline$0.0445
+0.00% today
1Y Change
+345.00%
Window
Jun 23, 2025 → Jun 17, 2026
- Market Cap
- $30.00M
- Revenue Growth
- -21.9%
- EPS Growth
- +82.6%
- Dividend Yield
- 0.0%
Coverage: 254 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Zoono Group Limited (ZOONF) is a Consumer Defensive stock with a market cap of $30.00M and listed on OTC. The stock last traded around $0.04 and up 345.0% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of -21.9%, EPS growth of +82.6%, a dividend yield of 0.0%. What stands out right now is revenue -21.9%, EPS +82.6%, free cash flow +76.4% with operating margin -328.3% and ROIC -61.6%. Valuation already assumes a fairly strong business story at price/sales 29.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines ZOONF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-21.9% vs +1.7% peer median
Operating Margin
Below sector median
-328.3% vs +6.6% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating picture looks softer than before
Revenue is at -21.9% and EPS is at +82.6%, with operating margin around -328.3%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
ZOONF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
ZOONF Max Drawdown
-40.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for ZOONF and SPY.
Company Overview
Zoono Group Limited
Other OTC
Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand and internationally. The company's products include hand sanitizers, textile applicators, mould remediation, and surface sanitizers. It serves airlines, healthcare, childcare, facilities management, transportation, education, and hospitality sectors. The company was incorporated in 1986 and is headquartered in Auckland, New Zealand.
- Leadership
- Paul Hyslop
- IPO Date
- Feb 24, 2020
- Employees
- 1
- Street Address
- 24 Bishop Dunn Place
- Mailing
- Auckland, 2013
- Region
- Auckland, NZ
- Reporting Currency
- USD
- Investor Line
- 64 2 165 9977
- Last Updated
- May 6, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- —
- Price/Sales
- 29.1
- Price/Book
- 7.7
Growth
- Revenue
- -21.9%
- EPS
- +82.6%
- Free Cash Flow
- +76.4%
Profitability
- Gross Margin
- -74.6%
- Operating Margin
- -328.3%
- Net Margin
- -369.4%
- ROE
- -108.9%
- ROIC
- -61.6%
Balance Sheet
- Debt/Equity
- 0.18
- Current Ratio
- 5.00
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.